Article info

Download PDFPDF
Research paper
KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy

Authors

  1. Correspondence to Dr Eugen Trinka, Department of Neurology, Paracelsus Medical University, Christian Doppler Klinik, Ignaz Harrer Strasse 79, A-5020 Salzburg, Austria; e.trinka{at}salk.at
View Full Text

Citation

Trinka E, Marson AG, Van Paesschen W, et al
KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy

Publication history

  • Received April 22, 2011
  • Revised May 15, 2012
  • Accepted July 13, 2012
  • First published August 29, 2012.
Online issue publication 
September 02, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.